Case Studies


Media Relations and Thought Leadership

Global, Clinical, Public

AC Immune is an international company on Nasdaq with broad pipeline in neurodegenerative diseases. The company has partnerships with leading international pharmaceutical companies for development of AD treatments. The goal was to raise visibility as a thought leader in neurodegenerative diseases – highlighting the company’s roadmap to success in AD. Further, the goal was to increase visibility in national, business and trade publications in the U.S.

LHS Solution

  • Increase AC Immune’s brand awareness throughout the U.S.​ aiming for high profile media outlets while building and cementing relationships with top journalists
  • Build awareness of AC Immune’s diversified therapeutic and diagnostic pipeline
  • Position CEO as a major thought leader/expert in the neurodegenerative disease space
  • Build and cement relationships amongst target audiences​
  • Differentiate AC Immune from its competitors in the marketplace


  • Cohesive, integrated communication strategy plan with flawless execution
  • Top mentions and original articles in Forbes, Reuters, PharmaVoice, Endpoints, FierceBiotech, In Vivo, BioWorld, BioSpace and STAT
  • Life Science Leader cover story
  • Secured 21 top-tier interviews, including with The Wall Street Journal, and Financial Times
  • Two thought leadership opinion/expert articles focused on the future of AD and technology platforms
  • Featured in two industry-leading podcasts including PharmaVoice Woman of the Week and the Bio Report by Dan Levine

Partner with us to build your winning company

Our experienced, multi-disciplined team provides seamless integrated communications, offering strategy consulting, investor and corporate communications and public relations/marketing.